Boehringer Ingelheim News Releases
See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.
News Archive
15.07.2008
Boehringer Ingelheim FENS Award for Pascal Fries for his exceptional research in neuroscience
26.06.2008
Further steps in generation change at Boehringer Ingelheim
26.06.2008
European CHMP issues positive opinion on Cymbalta for the treatment of Generalised Anxiety Disorder
For medical media, outside the US only
25.06.2008
Following the decision by the Indian Patent Office:
- Boehringer Ingelheim will not legally contest the decision
- Generic manufacture of nevirapine for developing countries permitted since 2007 24.06.2008 New Aptivus® (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 18.06.2008 Micardis®-based regimens help more patients achieve their blood pressure goals For medical media, outside the US only 18.06.2008 Professor Albertino Damasceno is announced as winner of the ISH Boehringer Ingelheim Developing World Award during the 2008 International Society of Hypertension (ISH) Biennial Scientific Meeting 17.06.2008 Boehringer Ingelheim to acquire Actimis Pharmaceuticals 10.06.2008 New data shows pramipexole (Mirapexin®/Sifrol®) can significantly reduce limb pain in patients with Restless Legs Syndrome (RLS) For medical media, outside the US only 09.06.2008 Boehringer Ingelheim announces first positive health technology assessments for novel oral anticoagulant Pradaxa® (dabigatran etexilate) For medical media, outside the US only
- Boehringer Ingelheim will not legally contest the decision
- Generic manufacture of nevirapine for developing countries permitted since 2007 24.06.2008 New Aptivus® (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 18.06.2008 Micardis®-based regimens help more patients achieve their blood pressure goals For medical media, outside the US only 18.06.2008 Professor Albertino Damasceno is announced as winner of the ISH Boehringer Ingelheim Developing World Award during the 2008 International Society of Hypertension (ISH) Biennial Scientific Meeting 17.06.2008 Boehringer Ingelheim to acquire Actimis Pharmaceuticals 10.06.2008 New data shows pramipexole (Mirapexin®/Sifrol®) can significantly reduce limb pain in patients with Restless Legs Syndrome (RLS) For medical media, outside the US only 09.06.2008 Boehringer Ingelheim announces first positive health technology assessments for novel oral anticoagulant Pradaxa® (dabigatran etexilate) For medical media, outside the US only

